SEMLER SCIENTIFIC INC (SMLR) Stock Fundamental Analysis
USA - NASDAQ:SMLR - US81684M1045 - Common Stock
29.11 USD
+0.72 (+2.54%)
28.99 USD
-0.12 (-0.41%)
Taking everything into account, SMLR scores 5 out of 10 in our fundamental rating. SMLR was compared to 191 industry peers in the Health Care Equipment & Supplies industry. SMLR has an excellent profitability rating, but there are concerns on its financial health. SMLR has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
SMLR had positive earnings in the past year.
In the past year SMLR had a positive cash flow from operations.
Each year in the past 5 years SMLR has been profitable.
Each year in the past 5 years SMLR had a positive operating cash flow.
1.2 Ratios
SMLR has a better Return On Assets (7.09%) than 88.48% of its industry peers.
SMLR has a better Return On Equity (9.66%) than 83.77% of its industry peers.
SMLR has a better Return On Invested Capital (0.92%) than 68.06% of its industry peers.
SMLR had an Average Return On Invested Capital over the past 3 years of 20.14%. This is significantly above the industry average of 8.46%.
The 3 year average ROIC (20.14%) for SMLR is well above the current ROIC(0.92%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.09% | ||
| ROE | 9.66% | ||
| ROIC | 0.92% |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
1.3 Margins
With an excellent Profit Margin value of 86.20%, SMLR belongs to the best of the industry, outperforming 98.95% of the companies in the same industry.
SMLR's Profit Margin has improved in the last couple of years.
The Operating Margin of SMLR (12.16%) is better than 79.06% of its industry peers.
SMLR's Operating Margin has improved in the last couple of years.
SMLR has a Gross Margin of 90.91%. This is amongst the best in the industry. SMLR outperforms 98.43% of its industry peers.
In the last couple of years the Gross Margin of SMLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.16% | ||
| PM (TTM) | 86.2% | ||
| GM | 90.91% |
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SMLR is creating value.
SMLR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SMLR has more shares outstanding
SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
SMLR has an Altman-Z score of 2.17. This is not the best score and indicates that SMLR is in the grey zone with still only limited risk for bankruptcy at the moment.
SMLR has a Altman-Z score of 2.17. This is in the better half of the industry: SMLR outperforms 64.40% of its industry peers.
SMLR has a debt to FCF ratio of 7.90. This is a slightly negative value and a sign of low solvency as SMLR would need 7.90 years to pay back of all of its debts.
SMLR has a better Debt to FCF ratio (7.90) than 75.92% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that SMLR is not too dependend on debt financing.
SMLR's Debt to Equity ratio of 0.25 is in line compared to the rest of the industry. SMLR outperforms 53.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 7.9 | ||
| Altman-Z | 2.17 |
ROIC/WACC0.11
WACC8.69%
2.3 Liquidity
SMLR has a Current Ratio of 0.60. This is a bad value and indicates that SMLR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.60, SMLR is not doing good in the industry: 91.62% of the companies in the same industry are doing better.
A Quick Ratio of 0.58 indicates that SMLR may have some problems paying its short term obligations.
The Quick ratio of SMLR (0.58) is worse than 90.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.58 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 201.43% over the past year.
The Earnings Per Share has been growing by 24.17% on average over the past years. This is a very strong growth
The Revenue for SMLR has decreased by -30.40% in the past year. This is quite bad
SMLR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.43% yearly.
EPS 1Y (TTM)201.43%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%687.5%
Revenue 1Y (TTM)-30.4%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-43.19%
3.2 Future
SMLR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -27.06% yearly.
SMLR is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -16.29% yearly.
EPS Next Y-162.03%
EPS Next 2Y-42.88%
EPS Next 3Y-27.06%
EPS Next 5YN/A
Revenue Next Year-40.74%
Revenue Next 2Y-23.76%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 3.46, the valuation of SMLR can be described as very cheap.
Based on the Price/Earnings ratio, SMLR is valued cheaper than 98.43% of the companies in the same industry.
SMLR is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
SMLR is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.46 | ||
| Fwd PE | N/A |
4.2 Price Multiples
62.83% of the companies in the same industry are more expensive than SMLR, based on the Enterprise Value to EBITDA ratio.
SMLR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SMLR is cheaper than 79.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.37 | ||
| EV/EBITDA | 88.3 |
4.3 Compensation for Growth
SMLR has an outstanding profitability rating, which may justify a higher PE ratio.
SMLR's earnings are expected to decrease with -27.06% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.14
EPS Next 2Y-42.88%
EPS Next 3Y-27.06%
5. Dividend
5.1 Amount
No dividends for SMLR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
29.11
+0.72 (+2.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners61.19%
Inst Owner Change40.39%
Ins Owners5.29%
Ins Owner Change0.32%
Market Cap430.83M
Analysts82.22
Price Target87.04 (199%)
Short Float %19.22%
Short Ratio4.04
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.93%
PT rev (3m)20.19%
EPS NQ rev (1m)-5.26%
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.32%
EPS NY rev (3m)-291.76%
Revenue NQ rev (1m)1.05%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.14%
Revenue NY rev (3m)-41.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.46 | ||
| Fwd PE | N/A | ||
| P/S | 10.02 | ||
| P/FCF | 35.37 | ||
| P/OCF | 34.58 | ||
| P/B | 1.12 | ||
| P/tB | N/A | ||
| EV/EBITDA | 88.3 |
EPS(TTM)8.41
EY28.89%
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)0.82
FCFY2.83%
OCF(TTM)0.84
OCFY2.89%
SpS2.9
BVpS25.91
TBVpS-7.67
PEG (NY)N/A
PEG (5Y)0.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.09% | ||
| ROE | 9.66% | ||
| ROCE | 1.08% | ||
| ROIC | 0.92% | ||
| ROICexc | 0.95% | ||
| ROICexgc | N/A | ||
| OM | 12.16% | ||
| PM (TTM) | 86.2% | ||
| GM | 90.91% | ||
| FCFM | 28.34% |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
ROICexc(3y)84.34%
ROICexc(5y)123.7%
ROICexgc(3y)231.99%
ROICexgc(5y)212.29%
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexcg growth 3Y32.01%
ROICexcg growth 5Y21.37%
ROICexc growth 3Y-65.32%
ROICexc growth 5Y-45.58%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score3
Asset Turnover0.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 7.9 | ||
| Debt/EBITDA | 16.92 | ||
| Cap/Depr | 60.82% | ||
| Cap/Sales | 0.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 218.98% | ||
| Profit Quality | 32.88% | ||
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.58 | ||
| Altman-Z | 2.17 |
F-Score3
WACC8.69%
ROIC/WACC0.11
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)201.43%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%687.5%
EPS Next Y-162.03%
EPS Next 2Y-42.88%
EPS Next 3Y-27.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.4%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-43.19%
Revenue Next Year-40.74%
Revenue Next 2Y-23.76%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
EBIT growth 1Y-75.28%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year-327.64%
EBIT Next 3Y-39.26%
EBIT Next 5YN/A
FCF growth 1Y-37.74%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y-42.82%
OCF growth 3Y14.98%
OCF growth 5Y13.91%